latest news releases from the newsroom
Revance Therapeutics, Inc.
Revance Therapeutics Added to NASDAQ Biotechnology Index
NEWARK, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Revance Therapeutics, Inc. (Nasdaq:RVNC), a specialty biopharmaceutical company developing botulinum toxin products for the use in aesthetic and therapeutic indications, announced today that it has been selected for addition to the NASDAQ Biotechnology Index (Nasdaq:^NBI), which will become effective upon market open on Monday, December 22, 2014.
Intersect ENT to Present at J.P. Morgan Healthcare Conference
MENLO PARK, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Intersect ENT, Inc. (Nasdaq:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today announced that management is scheduled to present an overview of the company's business, including certain preliminary 2014 results and 2015 outlook, at the J.P. Morgan 33
Landmark Infrastructure Partners LP
Landmark Infrastructure Partners LP Announces Closing of Partial Exercise of Over-Allotment Option
EL SEGUNDO, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Landmark Infrastructure Partners LP (the "Partnership") (Nasdaq:LMRK) announced today that it has closed the issuance of 100,000 common units representing limited partner interests in the Partnership ("Common Units") at $19.00 per Common Unit, pursuant to the partial exercise of the option to purchase additional Common Units granted to the underwriters in connection with the Partnership's recent initial public offering of 2,650,000 Common Units, which closed on November 19, 2014. The Common Units trade on the NASDAQ Global Market under the ticker symbol "LMRK".
Northrim BanCorp, Inc.
Northrim BanCorp Names Joe Beedle President and CEO; Marc Langland Remains Chairman
ANCHORAGE, Alaska, Dec. 18, 2014 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. ("the Company") (Nasdaq:NRIM), the holding company for Northrim Bank (the "Bank"), today announced Joe Beedle will become President and Chief Executive Officer of the holding company, in addition to continuing to serve in these positions for the Bank, effective January 1, 2015.
Donegal Group Inc.
Donegal Group Inc. Announces Quarterly Dividend
MARIETTA, Pa., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Donegal Group Inc. (Nasdaq:DGICA) and (Nasdaq:DGICB) reported that its board of directors declared a regular quarterly cash dividend of $.1315 per share of the Company's Class A common stock and $.1160 per share of the Company's Class B common stock. The dividends are payable on February 16, 2015 to stockholders of record as of the close of business on February 2, 2015.